SOLID BIOSCIENCES INC's ticker is SLDB and the CUSIP is 83422E105. A total of 78 filers reported holding SOLID BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $36,000 | -34.5% | 29,604 | -6.6% | 0.00% | – |
| Q4 2021 | $55,000 | -29.5% | 31,687 | -2.9% | 0.00% | – |
| Q3 2021 | $78,000 | -36.1% | 32,635 | -2.3% | 0.00% | – |
| Q2 2021 | $122,000 | +34.1% | 33,411 | +103.9% | 0.00% | – |
| Q1 2021 | $91,000 | -26.6% | 16,387 | +0.3% | 0.00% | – |
| Q4 2020 | $124,000 | +313.3% | 16,343 | +10.6% | 0.00% | – |
| Q3 2020 | $30,000 | -31.8% | 14,780 | -2.2% | 0.00% | – |
| Q2 2020 | $44,000 | +57.1% | 15,116 | +29.9% | 0.00% | – |
| Q1 2020 | $28,000 | -49.1% | 11,634 | -5.5% | 0.00% | – |
| Q4 2019 | $55,000 | -57.0% | 12,307 | -0.8% | 0.00% | -100.0% |
| Q3 2019 | $128,000 | +132.7% | 12,410 | +29.0% | 0.00% | – |
| Q2 2019 | $55,000 | -23.6% | 9,621 | +23.8% | 0.00% | – |
| Q1 2019 | $72,000 | -66.5% | 7,772 | -3.1% | 0.00% | -100.0% |
| Q4 2018 | $215,000 | -43.6% | 8,024 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $381,000 | +80.6% | 8,085 | +36.3% | 0.00% | 0.0% |
| Q2 2018 | $211,000 | +379.5% | 5,931 | +2.2% | 0.00% | – |
| Q1 2018 | $44,000 | – | 5,803 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,929,918 | $13,877,000 | 1.10% |
| EcoR1 Capital, LLC | 9,202,702 | $16,105,000 | 0.51% |
| RA Capital Management | 12,367,873 | $21,644,000 | 0.38% |
| Perceptive Advisors | 26,825,104 | $46,944,000 | 0.36% |
| Boxer Capital, LLC | 3,177,702 | $5,561,000 | 0.22% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,287,193 | $11,003,000 | 0.21% |
| Artal Group S.A. | 3,000,000 | $5,250,000 | 0.14% |
| Ikarian Capital, LLC | 521,155 | $911,000 | 0.14% |
| CAXTON ASSOCIATES LP | 177,571 | $311,000 | 0.03% |
| ALGERT GLOBAL LLC | 136,138 | $238,000 | 0.03% |